NSEOutcome of Board Meeting28 Sept 2026 · 28 Sept 2026, 08:55 pm
Outcome of Board Meeting
Bliss GVS Pharma Limited · BLISSGVS
✦ AI SummaryPromoter Reclassif.
Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of the 2nd Board Meeting held on September 28, 2026, where the Board has taken note of the re-classification of the erstwhile members of the promoter and promoter group of the Company from the “promoter/promoter group” category to the “public” category, in accordance with Regulation 31A(10) of the SEBI Listing Regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of the 2nd Board Meeting held on September 28, 2026 at shorter Notice regarding re-classification from the "Promoter and Promoter Group" category to the "public" category.
Attachments (1)
📄pdf
Download →
BLISSGVS_28092026205539_Outcome___BM___Bliss_GVS___2ndBM.pdf
View document text
September 28, 2026
To To
The Manager, Listing Department The General Manager, Listing Department
National Stock Exchange of India Limited BSE Limited
Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (East), Dalal Street,
Mumbai- 400 051 Mumbai- 400 001
Symbol: BLISSGVS Scrip Code: 506197
Dear Sir/Madam,
Subject: Outcome of board meeting pursuant to Regulation 30 read with Regulation 31A of
the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 ("SEBI Listing Regulations").
Ref: Regulation 31A(10) of the SEBI Listing Regulations in relation to re-classification from
the “promoter and promoter group” category to the “public” category.
Pursuant to Regulations 30 and 31A(10) read with Schedule III of the SEBI Listing Regulations,
we wish to inform you that the board of directors of Bliss GVS Pharma Limited (the
“Company”), at its meeting held today, i.e. Monday, September 28, 2026, has, inter alia, taken
note of the consummation of the transaction contemplated under the share purchase
agreement dated May 23, 2026 (“SPA”), entered into amongst Anupam Rasayan India Limited
(“Purchaser”), the Sellers (as defined therein) read with the deed of adherence dated July 17,
2026 (“DOA”) executed between Mates Visa Consultancy Private Limited (“PAC”) and the
Purchaser whereby the Purchaser had assigned its rights under the SPA to PAC (collectively,
“Transaction Documents”).
Pursuant to the consummation of the underlying transaction contemplated under the
Transaction Documents on September 28, 2026, (including the transfer of the equity shares
held by the Promoter Sellers (as defined in the SPA) to the Purchaser/PAC) and completion of
the open offer made by the Purchaser in accordance with the Securities and Exchange Board
of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended and
the consequent acquisition of control of the Company by the Purchaser/PAC, the Board has
taken note of the re-classification of the erstwhile members of the promoter and promoter
group of the Company from the “promoter/promoter group” category to the “public”
category, in accordance with Regulation 31A(10) of the SEBI Listing Regulations.
Accordingly, the details of the Promoters and Promoter Group members who have ceased to
be in control of the Company and stand re-classified from the “promoter/promoter group”
category to the “public” category pursuant to Regulation 31A(10) of the SEBI Listing
Regulations (collectively referred to as the “Outgoing Promoters”) are set out below:
Promoters and Promoters group reclassifying as public Category
No. Name of No. of % of No. of % of
Persons equity shareholding equity Shareholding
shares held prior to shares Held post
prior to Completion post Completion
Completion Completion
1. Shruti Vishal Rao 21,10,000 1.98% Nil 0.00%
2. Vibha Gagan
25,75,000 2.42% Nil 0.00%
Sharma
3. Narsimha
3,24,37,024 30.51% Nil 0.00%
Shibroor Kamath
4. Gagan Harsh
Nil 0.00% Nil 0.00%
Sharma
5. Shibroor
Gokuldas
8,000 0.01% 8,000 0.01%
Kamath
6. Ramdas
Vasudev Kamath 100 0.00% 100 0.00%
7. Punita Sharma Nil 0.00% Nil 0.00%
8. Ramdas
Nil 0.00% Nil 0.00%
Vasudev Kamath
9. Geeta Narsimha
Nil 0.00% Nil 0.00%
Kamath
10. Shibroor Ravidas
Nil 0.00% Nil 0.00%
Kamath
11. Vishal Vijay Rao Nil 0.00% Nil 0.00%
12. Shiv Kumar
Nil 0.00% Nil 0.00%
Sharma
13. Radha Sharma Nil 0.00% Nil 0.00%
14. Shagun Sharma Nil 0.00% Nil 0.00%
15. Lalneet Sharma Nil 0.00% Nil 0.00%
16. Vijay
Bhawanishanker Nil 0.00% Nil 0.00%
17. Meera Vijay Rao Nil 0.00% Nil 0.00%
18. Radha Nayak Nil 0.00% Nil 0.00%
19. Jagdishchandra
Nil 0.00% Nil 0.00%
Dhutia
20. Rajendra Bhatia Nil 0.00% Nil 0.00%
21. Madhuri
Nil 0.00% Nil 0.00%
Naygandhi
22. Lalita Bhatia Nil 0.00% Nil 0.00%
23. Vinita Siddhesh Nil 0.00% Nil 0.00%
Shenoy
24. GVSK LLP Nil 0.00% Nil 0.00%
25. GNR Enterprises Nil 0.00% Nil 0.00%
26. Aayushi Realtors
Nil 0.00% Nil 0.00%
27. Keetup India
Nil 0.00% Nil 0.00%
Private Limited
Total 3,71,30,124 34.82% 8,100 0.01%
In this regard, we wish to further inform you that:
1. The intent of the Outgoing Promoters to cease to be promoters/promoter group
members of the Company pursuant to consummation of the transaction envisaged
under the SPA and to be reclassified from the “promoter” category to the “public”
category in accordance with Regulation 31A(10) of the Listing Regulations was, inter
alia, specifically disclosed in the letter of offer dated 18 July 2026 (“LOF”) issued by
the Incoming Promoter in relation to the open offer made in accordance with the
Takeover Regulations. Paragraphs 6 of Section III(A) (Background to the Open Offer) and
paragraph 3 of Section VI (Background of the Sellers) of the LOF, inter alia, state that
pursuant to the consummation of the transaction contemplated in the SPA, the
Outgoing Promoters shall cease to be in control of the Company and will be re-
classified from the “promoter” category of the Company to the “public” category with
effect from, and immediately upon, the consummation of the SPA, in accordance with
the Listing Regulations.
2. The Outgoing Promoters have confirmed compliance with Regulation 31A(3)(b) of the
Listing Regulations and undertaken to comply with the requirements under
Regulation 31A(4) of the Listing Regulations.
3. The Company is in compliance with sub-clauses (c)(ii) and (c)(iii) of sub-regulation (3)
of Regulation 31(A) of the Listing Regulations.
The meeting of the Board of Directors commenced at 07:05 p.m. and concluded at 07:18 p.m.
Kindly take the above information on your record and acknowledge.
Thanking you,
Yours Faithfully,
For Bliss GVS Pharma Limited
Aditi Bhatt
Company Secretary & Compliance Officer